An economic model of long-term use of celecoxib in patients with osteoarthritis

Autor Loyd, Michael, Rublee, Dale, Jacobs, Philip
Vydáno 2007

The association of comorbidities, utilization and costs for patients identified with low back pain

Autor Ritzwoller, Debra P, Crounse, Laurie, Shetterly, Susan, Rublee, Dale
Vydáno 2006

Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]

Autor Rublee, Dale, Opal, Steven M, Schramm, Wolfgang, Keinecke, Heinz-Otto, Knaub, Sigurd
Vydáno 2002

Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

Autor Lanitis, Tereza, Leipold, Robert, Hamilton, Melissa, Rublee, Dale, Quon, Peter, Browne, Chantelle, Cohen, Alexander T.
Vydáno v BMC Health Serv Res (2017)

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation

Autor Dorian, Paul, Kongnakorn, Thitima, Phatak, Hemant, Rublee, Dale A., Kuznik, Andreas, Lanitis, Tereza, Liu, Larry Z., Iloeje, Uchenna, Hernandez, Luis, Lip, Gregory Y.H.
Vydáno 2014

Reverse Engineering and Evaluation of Prediction Models for Progression to Type 2 Diabetes: An Application of Machine Learning Using Electronic Health Records

Autor Anderson, Jeffrey P., Parikh, Jignesh R., Shenfeld, Daniel K., Ivanov, Vladimir, Marks, Casey, Church, Bruce W., Laramie, Jason M., Mardekian, Jack, Piper, Beth Anne, Willke, Richard J., Rublee, Dale A.
Vydáno v J Diabetes Sci Technol (2015)